| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Action of snake venom components on the haemostatic system
|
Hutton, R.A.
|
|
1993
|
|
3 |
p. 176-189
14 p.
|
artikel
|
| 2 |
Acute myeloid leukemia in the elderly
|
Harousseau, J.-L
|
|
1998
|
|
3 |
p. 145-153
9 p.
|
artikel
|
| 3 |
After 10years of JAK2V617F: Disease biology and current management strategies in polycythaemia vera
|
Grinfeld, Jacob
|
|
2017
|
|
3 |
p. 101-118
18 p.
|
artikel
|
| 4 |
AIDS-related lymphoma
|
Tulpule, A.
|
|
1999
|
|
3 |
p. 147-150
4 p.
|
artikel
|
| 5 |
AIDS: The safety of blood and blood products
|
Contreras, Marcela
|
|
1987
|
|
3 |
p. 212-
1 p.
|
artikel
|
| 6 |
A logical approach to the investigation of red cell enzymopathies
|
Lestas, A.N.
|
|
1990
|
|
3 |
p. 148-157
10 p.
|
artikel
|
| 7 |
A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury
|
Jodele, Sonata
|
|
2015
|
|
3 |
p. 191-204
14 p.
|
artikel
|
| 8 |
Angiodysplasia as a cause of iron deficiency anaemia
|
Hemingway, A.B.
|
|
1989
|
|
3 |
p. 147-151
5 p.
|
artikel
|
| 9 |
Aplastic anaemia: Management
|
Killick, S.B.
|
|
2000
|
|
3 |
p. 157-171
15 p.
|
artikel
|
| 10 |
Approval of the first protease-activated receptor antagonist: Rationale, development, significance, and considerations of a novel anti-platelet agent
|
French, Shauna L.
|
|
2015
|
|
3 |
p. 179-189
11 p.
|
artikel
|
| 11 |
A promising sword of tomorrow: Human γδ T cell strategies reconcile allo-HSCT complications
|
Hu, Yongxian
|
|
2016
|
|
3 |
p. 179-188
10 p.
|
artikel
|
| 12 |
Arenaviral haemorrhagic fevers
|
Cummins, D.
|
|
1991
|
|
3 |
p. 129-137
9 p.
|
artikel
|
| 13 |
Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies
|
Tallman, M.S.
|
|
2001
|
|
3 |
p. 133-142
10 p.
|
artikel
|
| 14 |
Aspirin for prevention and treatment of venous thromboembolism
|
Becattini, Cecilia
|
|
2014
|
|
3 |
p. 103-108
6 p.
|
artikel
|
| 15 |
Autocrine growth factors and leukaemic haemopoiesis
|
Russell, N.H.
|
|
1992
|
|
3 |
p. 149-156
8 p.
|
artikel
|
| 16 |
Autologous bone marrow transplantation in acute lymphoblastic leukaemia
|
Jackson, G.H.
|
|
1994
|
|
3 |
p. 161-168
8 p.
|
artikel
|
| 17 |
Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia
|
Butler, Tom
|
|
2010
|
|
3 |
p. 135-141
7 p.
|
artikel
|
| 18 |
Bleeding risks associated with vitamin K antagonists
|
Linkins, Lori-Ann
|
|
2013
|
|
3 |
p. 111-118
8 p.
|
artikel
|
| 19 |
Bloodstream infections in haematology: Risks and new challenges for prevention
|
Worth, Leon J.
|
|
2009
|
|
3 |
p. 113-122
10 p.
|
artikel
|
| 20 |
Cell cycle regulation
|
Bybee, A.
|
|
1991
|
|
3 |
p. 177-192
16 p.
|
artikel
|
| 21 |
Cell therapies for hematological malignancies: don't forget non-gene-modified t cells!
|
Grant, Melanie L.
|
|
2018
|
|
3 |
p. 203-224
|
artikel
|
| 22 |
Chimeric antigen receptor T cell therapy: 25years in the making
|
Gill, Saar
|
|
2016
|
|
3 |
p. 157-167
11 p.
|
artikel
|
| 23 |
2-Chloro-2′-deoxyadenosine: clinical applications in hematology
|
Delannoy, A.
|
|
1996
|
|
3 |
p. 148-166
19 p.
|
artikel
|
| 24 |
Chromogenic substrates in haemostasis
|
Hutton, R.A.
|
|
1987
|
|
3 |
p. 201-206
6 p.
|
artikel
|
| 25 |
Chronic lymphocytic leukaemia: the nature of the leukaemic cell
|
Hamblin, Terry J.
|
|
1997
|
|
3 |
p. 119-128
10 p.
|
artikel
|
| 26 |
Chronic lymphocytic leukaemia treatment
|
Montserrat, E.
|
|
1993
|
|
3 |
p. 164-175
12 p.
|
artikel
|
| 27 |
Circulating microparticles: pathophysiology and clinical implications
|
Piccin, Andrea
|
|
2007
|
|
3 |
p. 157-171
15 p.
|
artikel
|
| 28 |
Classification of acute leukaemias
|
Hayhoe, F.G.J.
|
|
1988
|
|
3 |
p. 186-193
8 p.
|
artikel
|
| 29 |
Clinical erythrokinetics: a critical review
|
Erslev, Allan J.
|
|
1997
|
|
3 |
p. 160-167
8 p.
|
artikel
|
| 30 |
Clinical indications for desmopressin (DDAVP) in congenital and acquired von Willebrand disease
|
Rodeghiero, F.
|
|
1991
|
|
3 |
p. 155-161
7 p.
|
artikel
|
| 31 |
Clinical, laboratory and imaging findings in Castleman's disease – The subtype decides
|
Haap, Michael
|
|
2018
|
|
3 |
p. 225-234
|
artikel
|
| 32 |
Clinical use of hematopoietic growth factors in allogeneic bone marrow transplantation
|
Lazarus, H.M.
|
|
1994
|
|
3 |
p. 169-178
10 p.
|
artikel
|
| 33 |
Clinical use of intravenous immunoglobulin in blood disorders
|
Newland, A.C.
|
|
1988
|
|
3 |
p. 157-167
11 p.
|
artikel
|
| 34 |
Clonal eosinophilic disorders and the hypereosinophilic syndrome
|
Brito-Babapulle, F.
|
|
1997
|
|
3 |
p. 129-145
17 p.
|
artikel
|
| 35 |
CNS prophylaxis in diffuse large B-cell lymphoma: If, when, how and for whom?
|
Siegal, Tali
|
|
2012
|
|
3 |
p. 97-106
10 p.
|
artikel
|
| 36 |
Congenital dyserythropoietic anaemias: clinical features, haematological morphology and new biochemical data
|
Wickramasinghe, S.N.
|
|
1998
|
|
3 |
p. 178-200
23 p.
|
artikel
|
| 37 |
Control of von Willebrand factor multimer size and implications for disease
|
Pimanda, John
|
|
2002
|
|
3 |
p. 185-192
8 p.
|
artikel
|
| 38 |
Cross-talk between platelet and tumor microenvironment: Role of multiligand/RAGE axis in platelet activation
|
Fuentes, Eduardo
|
|
2016
|
|
3 |
p. 213-221
9 p.
|
artikel
|
| 39 |
Current opinion in essential thrombocythemia: pathogenesis, diagnosis, and management
|
Tefferi, A.
|
|
2001
|
|
3 |
p. 121-131
11 p.
|
artikel
|
| 40 |
Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia
|
Apelseth, Torunn O.
|
|
2011
|
|
3 |
p. 113-122
10 p.
|
artikel
|
| 41 |
Cyclic neutropenia: A clinical review
|
Dale, D.C.
|
|
1988
|
|
3 |
p. 178-185
8 p.
|
artikel
|
| 42 |
Cytokines at the research-clinical interface: potential applications
|
Holyoake, T.L.
|
|
1996
|
|
3 |
p. 189-200
12 p.
|
artikel
|
| 43 |
Cytomegalovirus and blood transfusion
|
Barbara, J.A.J.
|
|
1987
|
|
3 |
p. 207-211
5 p.
|
artikel
|
| 44 |
Deoxyuridine suppression: Biochemical basis and diagnostic applications
|
Wickramasinghe, S.N.
|
|
1988
|
|
3 |
p. 168-177
10 p.
|
artikel
|
| 45 |
Desmopressin in treatment of haematological disorders and in prevention of surgical bleeding
|
Svensson, Peter J.
|
|
2014
|
|
3 |
p. 95-102
8 p.
|
artikel
|
| 46 |
Detection and measurement of cytokines
|
Thorpe, R.
|
|
1992
|
|
3 |
p. 133-148
16 p.
|
artikel
|
| 47 |
Diabetes mellitus as a poor mobilizer condition
|
Fadini, Gian Paolo
|
|
2018
|
|
3 |
p. 184-191
|
artikel
|
| 48 |
Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia
|
Berentsen, Sigbjørn
|
|
2012
|
|
3 |
p. 107-115
9 p.
|
artikel
|
| 49 |
Disorders of cobalamin (Vitamin B12) metabolism: Emerging concepts in pathophysiology, diagnosis and treatment
|
Solomon, Lawrence R.
|
|
2007
|
|
3 |
p. 113-130
18 p.
|
artikel
|
| 50 |
Disorders of neutrophil function
|
Bogomolski-Yahalom, V.
|
|
1995
|
|
3 |
p. 183-190
8 p.
|
artikel
|
| 51 |
Does antithrombotic therapy improve survival in cancer patients?
|
Cunningham, Moya S.
|
|
2009
|
|
3 |
p. 129-135
7 p.
|
artikel
|
| 52 |
Dueling for dual inhibition: Means to enhance effectiveness of PI3K/Akt/mTOR inhibitors in AML
|
Herschbein, Lauren
|
|
2018
|
|
3 |
p. 235-248
|
artikel
|
| 53 |
Duration of anticoagulation: decision making based on absolute risk
|
Keeling, David
|
|
2006
|
|
3 |
p. 173-178
6 p.
|
artikel
|
| 54 |
Editorial Board
|
|
|
2003
|
|
3 |
p. i-
1 p.
|
artikel
|
| 55 |
Editorial board
|
|
|
2004
|
|
3 |
p. i-
1 p.
|
artikel
|
| 56 |
Editorial board
|
|
|
2005
|
|
3 |
p. i-
1 p.
|
artikel
|
| 57 |
Effectiveness and safety of combined antiplatelet and anticoagulant therapy: A critical review of the evidence from randomized controlled trials
|
Paikin, Jeremy S.
|
|
2011
|
|
3 |
p. 123-129
7 p.
|
artikel
|
| 58 |
Effects of chemotherapy on fertility
|
Barton, C.
|
|
1990
|
|
3 |
p. 187-195
9 p.
|
artikel
|
| 59 |
Eleventh International RES Congress and Twenty-Fourth National Meeting of the Reticuloendothelial Society
|
|
|
1987
|
|
3 |
p. 213-
1 p.
|
artikel
|
| 60 |
Epstein–Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease
|
Burns, David M
|
|
2004
|
|
3 |
p. 193-209
17 p.
|
artikel
|
| 61 |
Erratum
|
|
|
1998
|
|
3 |
p. 201-
1 p.
|
artikel
|
| 62 |
Ex vivo expansion of haemopoietic progenitor cells
|
Alcorn, M.J.
|
|
1996
|
|
3 |
p. 167-176
10 p.
|
artikel
|
| 63 |
Factor VIII structure and function
|
Foster, P.A.
|
|
1989
|
|
3 |
p. 180-191
12 p.
|
artikel
|
| 64 |
Farnesyl transferase inhibitors in myeloid malignancies
|
Lancet, Jeffrey E
|
|
2003
|
|
3 |
p. 123-129
7 p.
|
artikel
|
| 65 |
Ferritin for the clinician
|
Knovich, Mary Ann
|
|
2009
|
|
3 |
p. 95-104
10 p.
|
artikel
|
| 66 |
Follicular lymphoma: time for a re-think?
|
Gandhi, Maher K.
|
|
2005
|
|
3 |
p. 165-178
14 p.
|
artikel
|
| 67 |
Globalisation and blood safety
|
Farrugia, Albert
|
|
2009
|
|
3 |
p. 123-128
6 p.
|
artikel
|
| 68 |
Graft-versus-host disease— A histological perspective
|
Sloane, J.P.
|
|
1990
|
|
3 |
p. 196-203
8 p.
|
artikel
|
| 69 |
Haploidentical stem cell transplantation in leukemia
|
Aversa, F.
|
|
2001
|
|
3 |
p. 111-119
9 p.
|
artikel
|
| 70 |
Haploidentical transplantation for acute lymphoblastic leukemia in childhood
|
Klingebiel, Thomas
|
|
2004
|
|
3 |
p. 181-192
12 p.
|
artikel
|
| 71 |
Hematologic aspects of renal insufficiency
|
Schiller, G.J.
|
|
1989
|
|
3 |
p. 141-146
6 p.
|
artikel
|
| 72 |
Hematopoietic stem cell transplantation in sickle cell disease
|
Vermylen, Christiane
|
|
2003
|
|
3 |
p. 163-166
4 p.
|
artikel
|
| 73 |
Hereditary elliptocytosis, spherocytosis and related disorders: Consequences of a deficiency or a mutation of membrane skeletal proteins
|
Palek, J.
|
|
1987
|
|
3 |
p. 147-168
22 p.
|
artikel
|
| 74 |
Hereditary red cell enzymopathies
|
Arya, R.
|
|
1995
|
|
3 |
p. 165-175
11 p.
|
artikel
|
| 75 |
Hereditary spherocytosis: a review of the clinical and molecular aspects of the disease
|
Hassoun, H.
|
|
1996
|
|
3 |
p. 129-147
19 p.
|
artikel
|
| 76 |
High-dose Therapy for Breast Cancer
|
Vahdat, L.
|
|
1995
|
|
3 |
p. 191-200
10 p.
|
artikel
|
| 77 |
How best to use new therapies in multiple myeloma
|
Dingli, David
|
|
2010
|
|
3 |
p. 91-100
10 p.
|
artikel
|
| 78 |
How do you decide on hormone replacement therapy in women with risk of venous thromboembolism?
|
Lekovic, Danijela
|
|
2017
|
|
3 |
p. 151-157
7 p.
|
artikel
|
| 79 |
Human haemopoietic stem cell assays
|
Gordon, M.Y.
|
|
1993
|
|
3 |
p. 190-197
8 p.
|
artikel
|
| 80 |
Human immunodeficiency virus type 2 (HIV2)
|
Hughes, A.
|
|
1990
|
|
3 |
p. 158-164
7 p.
|
artikel
|
| 81 |
Human natural killer cell development and biology
|
Farag, Sherif S.
|
|
2006
|
|
3 |
p. 123-137
15 p.
|
artikel
|
| 82 |
Hyperleukocytosis, leukostasis and leukapheresis: Practice management
|
Ganzel, Chezi
|
|
2012
|
|
3 |
p. 117-122
6 p.
|
artikel
|
| 83 |
Immune checkpoint blockade: Releasing the brake towards hematological malignancies
|
Xia, Yi
|
|
2016
|
|
3 |
p. 189-200
12 p.
|
artikel
|
| 84 |
Immune regulation in multiple myeloma: the host–tumour conflict
|
Cook, G.
|
|
1999
|
|
3 |
p. 151-162
12 p.
|
artikel
|
| 85 |
Immunological aspects of blood transfusions
|
Brand, A.
|
|
2000
|
|
3 |
p. 130-144
15 p.
|
artikel
|
| 86 |
Immunoregulatory cell dysfunction in chronic B-cell leukemias
|
Zaknoen, S.L.
|
|
1990
|
|
3 |
p. 165-174
10 p.
|
artikel
|
| 87 |
Importance of genetics in chronic lymphocytic leukemia
|
Zenz, Thorsten
|
|
2011
|
|
3 |
p. 131-137
7 p.
|
artikel
|
| 88 |
Infectious complications of blood transfusion
|
Berkman, S.A.
|
|
1988
|
|
3 |
p. 206-210
5 p.
|
artikel
|
| 89 |
Inherited aplastic anaemias/bone marrow failure syndromes
|
Dokal, Inderjeet
|
|
2008
|
|
3 |
p. 141-153
13 p.
|
artikel
|
| 90 |
Inherited disorders of vitamin B12 metabolism
|
Rosenblatt, D.S.
|
|
1987
|
|
3 |
p. 177-182
6 p.
|
artikel
|
| 91 |
Inherited traits affecting platelet function
|
Salles, Isabelle I.
|
|
2008
|
|
3 |
p. 155-172
18 p.
|
artikel
|
| 92 |
Interaction of the protein C/protein S anticoagulant system, the endothelium and pregnancy
|
Clark, P.
|
|
1999
|
|
3 |
p. 127-146
20 p.
|
artikel
|
| 93 |
Interleukin-1 and hematopoiesis
|
Bagby Jr, G.C.
|
|
1989
|
|
3 |
p. 152-161
10 p.
|
artikel
|
| 94 |
Interpretation of cytogenetic and molecular results in patients treated for CML
|
Vigil, Carlos E.
|
|
2011
|
|
3 |
p. 139-146
8 p.
|
artikel
|
| 95 |
Iron disorders can mimic anything, so always test for them
|
Herbert, V.
|
|
1992
|
|
3 |
p. 125-132
8 p.
|
artikel
|
| 96 |
Kinetics of engraftment following allogeneic hematopoietic cell transplantation with reduced-intensity or nonmyeloablative conditioning
|
Baron, Frédéric
|
|
2005
|
|
3 |
p. 153-164
12 p.
|
artikel
|
| 97 |
Leucocyte depletion of blood components
|
Roddie, P.H.
|
|
2000
|
|
3 |
p. 145-156
12 p.
|
artikel
|
| 98 |
Lifting the mantle: Unveiling new treatment approaches in relapsed or refractory mantle cell lymphoma
|
Mussetti, Alberto
|
|
2015
|
|
3 |
p. 143-152
10 p.
|
artikel
|
| 99 |
Lupus anticoagulant
|
Creagh, M.D.
|
|
1991
|
|
3 |
p. 162-167
6 p.
|
artikel
|
| 100 |
Lymphomas and reactive lymphoid lesions in HIV infection
|
Bain, B.J.
|
|
1998
|
|
3 |
p. 154-162
9 p.
|
artikel
|
| 101 |
Management of acquired aplastic anaemia
|
Marsh, Judith C.W.
|
|
2005
|
|
3 |
p. 143-151
9 p.
|
artikel
|
| 102 |
Management of Jehovah’s Witness patients with haematological problems
|
Nash, Michael J
|
|
2004
|
|
3 |
p. 211-217
7 p.
|
artikel
|
| 103 |
Management of older adults with multiple myeloma
|
Palumbo, Antonio
|
|
2013
|
|
3 |
p. 133-142
10 p.
|
artikel
|
| 104 |
Management of refractory idiopathic thrombocytopenia
|
Firkin, B.G
|
|
1988
|
|
3 |
p. 149-156
8 p.
|
artikel
|
| 105 |
Management of Sickle Cell Disease; Lessons from the Jamaican Cohort Study
|
Serjeant, G.R.
|
|
1993
|
|
3 |
p. 137-145
9 p.
|
artikel
|
| 106 |
Management of symptomatic, untreated chronic lymphocytic leukemia
|
Kasamon, Yvette L.
|
|
2007
|
|
3 |
p. 143-156
14 p.
|
artikel
|
| 107 |
Management of viral hepatitis in hematologic malignancies
|
Firpi, Roberto J.
|
|
2008
|
|
3 |
p. 117-126
10 p.
|
artikel
|
| 108 |
Maximizing anthracycline tolerability in hematologic malignancies: Treat to each heart's content
|
Oliveira, Guilherme H.
|
|
2016
|
|
3 |
p. 169-178
10 p.
|
artikel
|
| 109 |
Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies
|
Hall, A.G.
|
|
1992
|
|
3 |
p. 163-173
11 p.
|
artikel
|
| 110 |
MHC restricted and non-restricted killer lymphocytes
|
Rees, R.C.
|
|
1990
|
|
3 |
p. 204-210
7 p.
|
artikel
|
| 111 |
MicroRNA: Defining a new niche in Leukemia
|
Fernandes, Queenie
|
|
2017
|
|
3 |
p. 129-138
10 p.
|
artikel
|
| 112 |
MicroRNAs in hematological malignancies
|
Lawrie, Charles H.
|
|
2013
|
|
3 |
p. 143-154
12 p.
|
artikel
|
| 113 |
Modeling myeloproliferative neoplasms: From mutations to mouse models and back again
|
Morotti, Alessandro
|
|
2017
|
|
3 |
p. 139-150
12 p.
|
artikel
|
| 114 |
Modifying perioperative blood loss
|
Hunt, B.J.
|
|
1991
|
|
3 |
p. 168-176
9 p.
|
artikel
|
| 115 |
Molecular basis of Glanzmann's Thrombasthenia and current strategies in treatment
|
Bellucci, S
|
|
2002
|
|
3 |
p. 193-202
10 p.
|
artikel
|
| 116 |
Monoclonal antibody (MoAb) therapy in non-Hodgkin's lymphomas
|
Lim, S.H.
|
|
1992
|
|
3 |
p. 157-162
6 p.
|
artikel
|
| 117 |
Monoclonal antibody therapy for lymphoma
|
Campbell, Peter
|
|
2003
|
|
3 |
p. 143-152
10 p.
|
artikel
|
| 118 |
Monoclonal gammopathy of undetermined significance
|
Kyle, Robert A.
|
|
1994
|
|
3 |
p. 135-141
7 p.
|
artikel
|
| 119 |
Monoclonal gammopathy: The good, the bad and the ugly
|
Glavey, Siobhan V.
|
|
2016
|
|
3 |
p. 223-231
9 p.
|
artikel
|
| 120 |
Neonatal alloimmune thrombocytopenia
|
Skacel, P.O
|
|
1989
|
|
3 |
p. 174-179
6 p.
|
artikel
|
| 121 |
Novel therapies for multiple myeloma
|
Ryoo, Joan J
|
|
2002
|
|
3 |
p. 167-174
8 p.
|
artikel
|
| 122 |
Optimizing platelet transfusion therapy
|
Heal, Joanna Mary
|
|
2004
|
|
3 |
p. 149-165
17 p.
|
artikel
|
| 123 |
Oral anticoagulants: Pharmacogenetics
|
D’Andrea, Giovanna
|
|
2008
|
|
3 |
p. 127-140
14 p.
|
artikel
|
| 124 |
Paroxysmal nocturnal hemoglobinuria: The biochemical defects and the clinical syndrome
|
Rosse, W.F
|
|
1989
|
|
3 |
p. 192-200
9 p.
|
artikel
|
| 125 |
Parvovirus B19 infection and hematopoiesis
|
Brown, K.E.
|
|
1995
|
|
3 |
p. 176-182
7 p.
|
artikel
|
| 126 |
Pathophysiology and management of inherited bone marrow failure syndromes
|
Shimamura, Akiko
|
|
2010
|
|
3 |
p. 101-122
22 p.
|
artikel
|
| 127 |
Perfluorinated blood substitutes and artificial oxygen carriers
|
Lowe, K.C.
|
|
1999
|
|
3 |
p. 171-184
14 p.
|
artikel
|
| 128 |
Plasma cell leukemia
|
Albarracin, Flavio
|
|
2011
|
|
3 |
p. 107-112
6 p.
|
artikel
|
| 129 |
Platelet actuation
|
Blockmans, D.
|
|
1995
|
|
3 |
p. 143-156
14 p.
|
artikel
|
| 130 |
Platelet procoagulant activity: physiological significance and mechanisms of exposure
|
Bevers, E.M.
|
|
1991
|
|
3 |
p. 146-154
9 p.
|
artikel
|
| 131 |
Platelet secretion: From haemostasis to wound healing and beyond
|
Golebiewska, Ewelina M.
|
|
2015
|
|
3 |
p. 153-162
10 p.
|
artikel
|
| 132 |
Primary cutaneous lymphomas: a review with current treatment options
|
Querfeld, Christiane
|
|
2003
|
|
3 |
p. 131-142
12 p.
|
artikel
|
| 133 |
Prophylaxis against late infection following splenectomy and bone marrow transplant
|
Fielding, Adele K.
|
|
1994
|
|
3 |
p. 179-191
13 p.
|
artikel
|
| 134 |
Purine metabolism as a target for leukemia chemotherapy
|
Riscoe, M.K.
|
|
1989
|
|
3 |
p. 162-173
12 p.
|
artikel
|
| 135 |
Recent discoveries in the molecular pathogenesis of the inherited bone marrow failure syndrome Fanconi anemia
|
Mamrak, Nicholas E.
|
|
2017
|
|
3 |
p. 93-99
7 p.
|
artikel
|
| 136 |
Red cell deformability and haematological disorders
|
Stuart, J.
|
|
1990
|
|
3 |
p. 141-147
7 p.
|
artikel
|
| 137 |
Regulating the regulators in cancer-immunosuppression in multiple myeloma (MM)
|
Feyler, Sylvia
|
|
2013
|
|
3 |
p. 155-164
10 p.
|
artikel
|
| 138 |
Reintroduction of anticoagulant therapy after intracranial haemorrhage: If and when?
|
Scott, Martin
|
|
2018
|
|
3 |
p. 256-263
|
artikel
|
| 139 |
Results of programmes for antenatal detection of thalassemia in reducing the incidence of the disorder
|
Cao, A.
|
|
1987
|
|
3 |
p. 169-176
8 p.
|
artikel
|
| 140 |
Review of neonatal red cell transfusion practices
|
Luban, N.L.C.
|
|
1994
|
|
3 |
p. 148-153
6 p.
|
artikel
|
| 141 |
Role of chromosomal abnormalities in chronic lymphocytic leukemia
|
Gahrton, G.
|
|
1987
|
|
3 |
p. 183-192
10 p.
|
artikel
|
| 142 |
Severe thalassaemia intermedia: clinical problems in the absence of hypertransfusion
|
Mohamed, N.
|
|
1998
|
|
3 |
p. 163-170
8 p.
|
artikel
|
| 143 |
Sex, thrombosis and inherited thrombophilia
|
Bleker, Suzanne M.
|
|
2014
|
|
3 |
p. 123-133
11 p.
|
artikel
|
| 144 |
Short- and Long-term exercise induced alterations in haemostasis: a review of the literature
|
Posthuma, Jelle J.
|
|
2015
|
|
3 |
p. 171-178
8 p.
|
artikel
|
| 145 |
Sickle cell disease and pregnancy
|
Koshy, M.
|
|
1995
|
|
3 |
p. 157-164
8 p.
|
artikel
|
| 146 |
Silencing and overexpression of human blood group antigens in transfusion: Paving the way for the next steps
|
Bagnis, Claude
|
|
2015
|
|
3 |
p. 163-169
7 p.
|
artikel
|
| 147 |
Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia
|
Mesa, R.A.
|
|
2000
|
|
3 |
p. 121-129
9 p.
|
artikel
|
| 148 |
Splenic irradiation in myelofibrosis with myeloid metaplasia: a review
|
Elliott, M.A.
|
|
1999
|
|
3 |
p. 163-170
8 p.
|
artikel
|
| 149 |
Splenomegaly: Investigation, diagnosis and management
|
Pozo, Anna L.
|
|
2009
|
|
3 |
p. 105-111
7 p.
|
artikel
|
| 150 |
Staining of the nucleolar organizer regions: relevance in hematology
|
Baatout, S.
|
|
1996
|
|
3 |
p. 185-188
4 p.
|
artikel
|
| 151 |
Stem-cell mobilization for autografting in chronic myeloid leukemia
|
Carella, A.M.
|
|
1997
|
|
3 |
p. 154-159
6 p.
|
artikel
|
| 152 |
Swallowing a bitter pill–oral arsenic trioxide for acute promyelocytic leukemia
|
Torka, Pallawi
|
|
2016
|
|
3 |
p. 201-211
11 p.
|
artikel
|
| 153 |
Targeted therapies for CLL: Practical issues with the changing treatment paradigm
|
Jain, Nitin
|
|
2016
|
|
3 |
p. 233-244
12 p.
|
artikel
|
| 154 |
The clinical impact of cytomegalovirus infection following allogeneic hematopoietic cell transplantation: Why the quest for meaningful prophylaxis still matters
|
Chan, Shawna T.
|
|
2017
|
|
3 |
p. 173-183
11 p.
|
artikel
|
| 155 |
The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia
|
Moorman, Anthony V.
|
|
2012
|
|
3 |
p. 123-135
13 p.
|
artikel
|
| 156 |
The current status of interferonα in haemic malignancy
|
Galvani, D.W.
|
|
1990
|
|
3 |
p. 175-180
6 p.
|
artikel
|
| 157 |
The cytokine receptor superfamily
|
Kaczmarski, R.S.
|
|
1991
|
|
3 |
p. 193-203
11 p.
|
artikel
|
| 158 |
The genetic basis of von Willebrand disease
|
Goodeve, Anne C.
|
|
2010
|
|
3 |
p. 123-134
12 p.
|
artikel
|
| 159 |
The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation
|
Riddell, Stanley R
|
|
2003
|
|
3 |
p. 153-162
10 p.
|
artikel
|
| 160 |
The management of chronic graft-versus-host disease
|
Siadak, Muriel
|
|
1994
|
|
3 |
p. 154-160
7 p.
|
artikel
|
| 161 |
The management of early Hodgkin's disease
|
Horwich, A.
|
|
1990
|
|
3 |
p. 181-186
6 p.
|
artikel
|
| 162 |
The management of perioperative bleeding
|
Koh, M.B.C
|
|
2003
|
|
3 |
p. 179-185
7 p.
|
artikel
|
| 163 |
The mystery of chronic lymphocytic leukemia (CLL): Why is it absent in Asians and what does this tell us about etiology, pathogenesis and biology?
|
Yang, Shen-Miao
|
|
2015
|
|
3 |
p. 205-213
9 p.
|
artikel
|
| 164 |
The natural history of HIV disease in haemophilia
|
Lee, C.A.
|
|
1998
|
|
3 |
p. 135-144
10 p.
|
artikel
|
| 165 |
The paradox of hemoglobin SC disease
|
Nagel, Ronald L.
|
|
2003
|
|
3 |
p. 167-178
12 p.
|
artikel
|
| 166 |
The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies
|
Twa, David D.W.
|
|
2018
|
|
3 |
p. 249-255
|
artikel
|
| 167 |
The pathogenesis and treatment of large granular lymphocyte leukemia
|
Steinway, Steven Nathaniel
|
|
2014
|
|
3 |
p. 87-94
8 p.
|
artikel
|
| 168 |
The post-thrombotic syndrome: current knowledge, controversies, and directions for future research
|
Kahn, Susan R
|
|
2002
|
|
3 |
p. 155-165
11 p.
|
artikel
|
| 169 |
The practical management of haemophilia
|
Winter, M
|
|
1992
|
|
3 |
p. 174-181
8 p.
|
artikel
|
| 170 |
The preleukemic syndrome (hematopoietic dysplasia)
|
Bagby Jr, G.C
|
|
1988
|
|
3 |
p. 194-205
12 p.
|
artikel
|
| 171 |
Therapy associated leukaemia
|
Devereux, S.
|
|
1991
|
|
3 |
p. 138-145
8 p.
|
artikel
|
| 172 |
Therapy-related myelodysplastic syndromes, or are they?
|
Abou Zahr, Abdallah
|
|
2017
|
|
3 |
p. 119-128
10 p.
|
artikel
|
| 173 |
The role of antilymphocyte globulin in the treatment of chronic acquired bone marrow failure
|
Marsh, J.C.W.
|
|
1988
|
|
3 |
p. 141-148
8 p.
|
artikel
|
| 174 |
The role of autologous bone marrow transplantation in the treatment of malignant disease
|
Goldstone, A.H.
|
|
1987
|
|
3 |
p. 193-200
8 p.
|
artikel
|
| 175 |
The role of fludarabine in hematological malignancies
|
Wright, S.J.
|
|
1994
|
|
3 |
p. 125-134
10 p.
|
artikel
|
| 176 |
The role of markers of bone remodeling in multiple myeloma
|
Terpos, Evangelos
|
|
2005
|
|
3 |
p. 125-142
18 p.
|
artikel
|
| 177 |
The role of mesenchymal stem cells in haemopoiesis
|
Dazzi, Francesco
|
|
2006
|
|
3 |
p. 161-171
11 p.
|
artikel
|
| 178 |
The role of splenectomy in autoimmune hematological disorders: Outdated or still worth considering?
|
Sys, Judith
|
|
2017
|
|
3 |
p. 159-172
14 p.
|
artikel
|
| 179 |
The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis
|
Winckers, Kristien
|
|
2013
|
|
3 |
p. 119-132
14 p.
|
artikel
|
| 180 |
The unstable haemoglobins
|
Williamson, D.
|
|
1993
|
|
3 |
p. 146-163
18 p.
|
artikel
|
| 181 |
The use of platelet function testing in PCI and CABG patients
|
Janssen, Paul W.A.
|
|
2014
|
|
3 |
p. 109-121
13 p.
|
artikel
|
| 182 |
The use of the polymerase chain reaction in haematology
|
Macintyre, E.A.
|
|
1989
|
|
3 |
p. 201-210
10 p.
|
artikel
|
| 183 |
Thrombin generation and fibrin clot structure
|
Wolberg, Alisa S.
|
|
2007
|
|
3 |
p. 131-142
12 p.
|
artikel
|
| 184 |
Thrombolytic therapy: 2001
|
Marder, V.J.
|
|
2001
|
|
3 |
p. 143-157
15 p.
|
artikel
|
| 185 |
Transfusion-related acute lung injury
|
Silliman, Christopher C.
|
|
2006
|
|
3 |
p. 139-159
21 p.
|
artikel
|
| 186 |
Transfusion virology: progress and challenges
|
Simmonds, P.
|
|
1998
|
|
3 |
p. 171-177
7 p.
|
artikel
|
| 187 |
Treatment of the neutropenia of Felty syndrome
|
Rashba, E.J.
|
|
1996
|
|
3 |
p. 177-184
8 p.
|
artikel
|
| 188 |
Umbilical cord blood transplantation – how, when and for whom?
|
Cohen, Yossi
|
|
2004
|
|
3 |
p. 167-179
13 p.
|
artikel
|
| 189 |
Unrelated donor umbilical cord blood transplant versus unrelated hematopoietic stem cell transplant in patients with acute leukemia: A meta-analysis and systematic review
|
Lou, Xiao
|
|
2018
|
|
3 |
p. 192-202
|
artikel
|
| 190 |
Use of radiactive phosphorus in haematology
|
Roberts, B.E.
|
|
1997
|
|
3 |
p. 146-153
8 p.
|
artikel
|
| 191 |
Use of single donor platelets
|
Kirkley, S.A.
|
|
1994
|
|
3 |
p. 142-147
6 p.
|
artikel
|
| 192 |
Vaccines for lymphomas: Idiotype vaccines and beyond
|
Houot, Roch
|
|
2009
|
|
3 |
p. 137-142
6 p.
|
artikel
|
| 193 |
Waldenström's macroglobulinaemia
|
Johnson, S.A
|
|
2002
|
|
3 |
p. 175-184
10 p.
|
artikel
|
| 194 |
When the good go bad: Mutant NPM1 in acute myeloid leukemia
|
Kunchala, Preethi
|
|
2018
|
|
3 |
p. 167-183
|
artikel
|
Tijdschrift beschrijving